
The study examined long cell-free DNA (cfDNA) in pregnant women's plasma and found promising results. Plasma samples from ten preeclamptic and sixteen normal pregnancies were analyzed using ddPCR assays targeting specific genes. Results revealed that preeclamptic patients had lower long cfDNA percentages compared to healthy pregnancies. The study suggests ddPCR as a cost-effective preeclampsia detection method with potential diagnostics applications.
Like
Save
Share